HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,000 | -61.9% | 130 | -60.6% | 0.00% | -100.0% |
Q1 2022 | $21,000 | +16.7% | 330 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $18,000 | -96.8% | 330 | -95.9% | 0.00% | -95.7% |
Q3 2021 | $568,814 | +5.9% | 8,058 | 0.0% | 0.02% | -4.2% |
Q2 2021 | $536,985 | -45.8% | 8,058 | -9.7% | 0.02% | -54.7% |
Q1 2021 | $990,875 | -10.6% | 8,926 | -4.4% | 0.05% | -15.9% |
Q4 2020 | $1,108,769 | +36.1% | 9,337 | 0.0% | 0.06% | +16.7% |
Q3 2020 | $814,653 | -6.0% | 9,337 | -3.5% | 0.05% | -19.4% |
Q2 2020 | $866,672 | -10.1% | 9,677 | 0.0% | 0.07% | -30.2% |
Q1 2020 | $964,410 | -21.2% | 9,677 | -9.1% | 0.10% | -11.1% |
Q4 2019 | $1,223,685 | -8.9% | 10,650 | 0.0% | 0.11% | -18.8% |
Q3 2019 | $1,343,391 | +4.8% | 10,650 | 0.0% | 0.13% | +3.9% |
Q2 2019 | $1,281,621 | +37.6% | 10,650 | 0.0% | 0.13% | +24.3% |
Q1 2019 | $931,662 | -12.6% | 10,650 | 0.0% | 0.10% | -25.9% |
Q4 2018 | $1,065,533 | -12.7% | 10,650 | 0.0% | 0.14% | +3.0% |
Q3 2018 | $1,220,277 | +26.9% | 10,650 | -0.6% | 0.14% | +19.5% |
Q2 2018 | $961,280 | +19.8% | 10,719 | -2.3% | 0.11% | +15.3% |
Q1 2018 | $802,492 | +20.5% | 10,969 | -4.4% | 0.10% | +19.5% |
Q4 2017 | $666,120 | +29.4% | 11,469 | 0.0% | 0.08% | +20.6% |
Q3 2017 | $514,614 | – | 11,469 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |